103P - Lobectomy for non-small cell lung cancer in octogenarians: A 7-year single center experience

Date 15 April 2016
Event European Lung Cancer Conference 2016 (ELCC) 2016
Session Poster lunch
Topics Non-Small Cell Lung Cancer
Geriatric Oncology
Surgical Oncology
Radiation Oncology
Presenter Nikolaos Panagiotopoulos
Citation Journal of Thoracic Oncology (2016) 11 (supplement 4): S57-S166. S1556-0864(16)X0004-4
Authors N. Panagiotopoulos1, D. Patrini2, S. De Cabanyes2, M. Hayward2, D. Lawrence2
  • 1Thoracic Surgery, University College London Hospital UCLH NHS Foundation Trust, W1G 8PH - London/GB
  • 2Thoracic Surgery, University College London Hospital UCLH NHS Foundation Trust, London/GB



Octogenarians with resectable early stage non-small cell lung cancer (NSCLC) have become nowadays part of the daily practice of a Thoracic Surgeon. We present a 7-year experience in lobectomies performed in octogenarians for early stage NSCLC and we compare the feasibility and outcomes with those reported in the literature


From 2007 to 2014 61 octogenarian patients underwent lobectomy for early stage NSCLC in our department. Patient demographics, preoperative oncological and functional assessment, surgical approach, postoperative course and complications were analysed.


61 patients (M/F = 36/25) with a mean age of 82.2 year old (range 80–89) underwent lobectomy (right upper = 24 patients; right middle = 2 patients; right lower = 13 patients; left upper = 13 patients; left lower = 9 patients). The 30 day mortality was 0%. Complications leading to prolonged hospital occurred in 26 patients (42.6%) with the most common being prolonged air leak in 10 patients (16%). Median stay in ITU was 1.2 days. Adenocarcinoma was the most common histologic type presenting in 28 patients (46%). 1-year survival rate was 95%.


Octogenarians with early stage NSCLC represent a sensitive group of patients that can be benefitted from lobectomy with acceptable morbidity and mortality risk. A careful preoperative selection remains the key feature in the management of these patients.

Clinical trial identification

Is a retrospective study.

Legal entity responsible for the study

University College London Hospitals (UCLH)


University College London Hospitals (UCLH)


All authors have declared no conflicts of interest.